about
Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model.Parity, lactation, bone strength, and 16-year fracture risk in adult women: findings from the Study of Women's Health Across the Nation (SWAN).Pleiotropic effects of obesity on fracture risk: the Study of Women's Health Across the NationBone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study.Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause.Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation.Ethnic variability in bone geometry as assessed by hip structure analysis: findings from the hip strength across the menopausal transition study.A comparison of DXA and CT based methods for estimating the strength of the femoral neck in post-menopausal womenBone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipientsMedication Use by Race and Ethnicity in Women Transitioning Through the Menopause: A Study of Women's Health Across the Nation Drug Epidemiology Study.Rates of bone loss among women initiating antidepressant medication use in midlifeTelemedicine for Reach, Education, Access, and Treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities.Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes.Characterizing the trajectories of vasomotor symptoms across the menopausal transition.Deploying the chronic care model to implement and sustain diabetes self-management training programs.Deficiencies of cardiovascular risk prediction models for type 1 diabetes.Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis."Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort.Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database.Who can provide diabetes self-management support in primary care? Findings from a randomized controlled trial.In a 12-year study, sustainability of quality of life benefits after liver transplantation varies with pretransplantation diagnosis.HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients.Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.Pathologist's perspective on liver needle biopsy size?The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation.Effects of depression and antidepressant use on goal setting and barrier identification among patients with type 2 diabetes.Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences.Post-transplantation growth among pediatric recipients of liver transplantation.Examining patient risk factors, comorbid conditions, participation, and physician referrals to a rural diabetes self-management education programEfficacy of the Telemedicine for Reach, Education, Access, and Treatment (TREAT) Model for Diabetes CareRe-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring?Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury testsDeveloping and validating a diabetes database in a large health systemUsing the American Association of Diabetes Educators Outcomes System to Identify Patient Behavior Change Goals and Diabetes Educator ResponsesChronic Rejection of Small Bowel Grafts: Pediatric and Adult Study of Risk Factors and Morphologic Progression
P50
Q33937293-CB043873-3042-4987-8C6B-01B2A70DD094Q35191670-2552B460-39E9-4DE0-8E3A-8F59D256C48FQ35492429-7647E7C6-710B-441E-9B8C-F4A15AB8C3E2Q35504164-FA130AFE-C110-4826-8553-87FCB2E366AEQ35578316-BD3E2FFE-1D60-4DAF-A759-511D95C57DCFQ36354523-DCE1BD4A-D72B-488F-9560-7067E5101FA5Q36652685-C3817C61-4C56-41DA-B9C0-1D60CBA39AE6Q36710257-42852124-2613-4F16-AFF8-6D82D0917E56Q36743913-DF6E0C82-904F-4D73-B8ED-E18EA94CFA6FQ36933028-0F2B4FA6-8FA1-497B-A5B6-31CC2973A6CEQ36987455-71CE0573-4201-44DB-B4A8-E76A23FA4E0BQ37275988-26AE2068-8F4C-444B-8AB5-432543990AE0Q38254103-5442B163-81A7-47AB-A286-2BE3E2217568Q38782843-C92D3AED-C448-48B3-8342-2726A3CFA72FQ39610437-E83C4BAB-AF1A-48B8-842C-BEF94EEDFD7FQ39749424-6F2DE7D7-8F5E-4A2B-8D3D-EE8844F7551CQ40302948-8C7D9E71-9D33-4CD1-AFB4-826E6381EC46Q40321256-FB07B271-330B-444E-8E64-6A401249B826Q40705019-E218C53D-2566-4AC8-B79C-2B557F195A60Q42263131-7DBFB549-1593-4ED4-97A5-35EE57A63E7BQ42271695-171D2691-34A0-4B16-87AC-1EA1A985A7DEQ42843885-7DECF7AE-BC62-4F63-BDE4-D4FC318D2C9DQ42987327-3A4CB802-AB5D-4ECA-8F0E-AE00C413F0DAQ43508603-2EEEBE35-FFBC-4233-B541-BC56F6A02032Q43611611-BE63A5C3-DB6B-427F-8C8D-237F742D1D28Q45058863-34AD7B94-1FE8-41C9-92A6-255A62B09E40Q46408086-0DF5D29C-85DB-4E76-8150-414BAB2D2C1CQ47447307-CD8C6A85-DBF5-411A-B920-94DF3200A315Q47707495-D2D741C4-E6E6-4765-8BB6-FEA5E668507EQ47947439-A87DF085-E82D-4DDA-BAAF-0C90C88B7BADQ48144436-593ED5A1-880D-47B2-AD08-7BADA27CD5E5Q51916087-C391B004-FB18-42E7-A8BC-AE9B7303EC60Q53287488-4A042E52-8D41-4AFA-8E00-1E2D0F4040B3Q56760452-386472F8-188E-453E-AB39-FC978D87D298Q62617329-BC96355D-EA3F-40B8-92F2-2874B146B04EQ62617379-BFAD8D49-5BF9-427B-B024-5EEB862AC75EQ62617432-9333E7AF-C3F8-4E0B-91EC-FEFEB176C0FFQ62617483-FBD84DE3-8969-4147-81B7-685A11A6F80FQ62617495-15939E93-7786-47B6-A495-169A1A242D56Q62617573-DF6F056F-DB6D-4D40-B0CE-862CD2A88E0E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kristine Ruppert
@ast
Kristine Ruppert
@en
Kristine Ruppert
@es
Kristine Ruppert
@nl
Kristine Ruppert
@sl
type
label
Kristine Ruppert
@ast
Kristine Ruppert
@en
Kristine Ruppert
@es
Kristine Ruppert
@nl
Kristine Ruppert
@sl
prefLabel
Kristine Ruppert
@ast
Kristine Ruppert
@en
Kristine Ruppert
@es
Kristine Ruppert
@nl
Kristine Ruppert
@sl
P1053
C-2555-2016
P106
P1153
7004157413
P21
P31
P3829
P496
0000-0002-3008-6584